Inspiring Scientific Discovery
Search hundreds of thousands of products backed by our one-year, replacement or money-back, satisfaction guarantee.
Bioss A.I. Panel Builder
Build your panel with our A.I. Powered Automated Panel Builder to set yourself up for success and clean results.
Select your cytometer, panel requirements, and panel details to receive your optimal AI designed panel.
Click here to view our latest promotions available until the end of September 2023
AbBy Fluor®, Bioss Brand of Fluorochromes
We are excited about the launch of AbBy Fluor®dyes. These bright and stable fluorochromes are supplied under Bioss brand, facilitating multiplex immunoassays.
Bioss IVD Raw Materials
The ultimate goal of Bioss is to improve the health and quality of life of humans and animals. To help cure, treat, or prevent diseases, Bioss has developed antibodies and proteins in support of the development of in vitro diagnostic (IVD) tests.
Check out our catalog of ~700 optimized Flow Cytometry antibodies available in a "100 tests" size and designed to deliver brilliant results in your experiments.
- Considerations of Fluorochrome Selection for Flow CytometryThere are many kinds of fluorochromes broadly used in flow cytometry. It is critical to choose the right ones for your flow cytometry assays. To facilitate you fluorochrome selection, we here outline a few key considerations for your reference.
- Site-Specific R-loops: A Promising New Approach for Treating Fragile X SyndromeJust in time for Fragile X Awareness Month, a recent groundbreaking publication titled "Site-specific R-loops induce CGG repeat contraction and fragile X gene reactivation" by Dr. Jeannie Lee and Dr. Hungoo Lee studies the molecular mechanisms and implications of R-loops in regulating gene transcription. This is particularly important to the study of fragile-X-associated disorders due to its potential to inform the development of novel treatment approaches.
- Exploring the Debate on Glial-to-Neuron ConversionOn June 7, Professor Seth Blackshaw from Johns Hopkins posted a Matters Arising in Nature, entitled "Ptbp1 deletion does not induce astrocyte-to-neuron conversion," to question a paper published earlier in Nature. This paper says that Ptbp1 knockdown does not induce glial-to-neuron conversion, reigniting the controversy over whether glial cells can be converted into neurons.
Bioss Pathway Maps
Diving into a new project? Get up to speed quickly with these cellular and molecular pathway maps. Each one is expertly researched and hand-drawn by our scientific team. Autophagy, Tumor Immunology, MAPK, WNT Signaling, and many others are available to download, print, and share at your convenience.
Bioss Inc is a leading antibody developer and manufacturer with state of the art technologies. We have developed over 11,000 primary antibodies and more than 130,000 derived products including fluorochrome conjugated antibodies. In addition to reliable loading control and tag antibodies, our catalog includes over 1000 specific antibodies recognizing proteins with phosphorylation, acetylation, or methylation modifications.